keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
Showing 1 of 1 Streams
ATMP Development & Manufacturing
08:55 - 09:00
Chairperson's Opening Remarks
- Felix Wittkopp - Director of Purification Development Gene Therapy - Gene Therapy Technical Research & Development, Roche, Germany
09:00 - 09:30
Fuelling the Future for Manufacturing recombinant AAV
- Frank Agbogbo - Vice President, Forge Biologics, USA
09:30 - 10:00
Ditching the Plasmid Dependency: Engineering a Resilient and Cost-Effective Raw Material Strategy for ATMP Pipelines
Showing 1 of 1 Streams
ATMP Development & Manufacturing
11:15 - 11:45
Building for the Future: Phase-Appropriate CMC Strategies
- A Representative from Resolution Therapeutics - (Pending Final Confirmation), Resolution Therapeutics
11:45 - 12:15
CASE STUDY: Bridging the Valley of Death - De-Risking ATMP Tech Transfer from Lab to GMP
- Pablo Mancheño Corvo - Associate Scientific Director, Takeda, Spain
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
